The Indian Pharmaceutical sector is expected to grow to US$100 billion by 2025. The market is expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest pharmaceutical market globally by absolute size. The Medical Devices industry in India is presently valued at US$ 5.2 billion and contributes 4-5% to the US$ 96.7 billion Indian health care industry. As per industry estimates, the Indian medical devices market will grow to US$ 50 billion by 2025.

LIFE SCIENCES EXECUTIVE COMMITTEE

The Life Sciences Executive Committee influences and advances policy and regulatory regimes by promoting best practices and market-based solutions to positively impact life sciences companies in both India and the United States. It formulates an annual work plan and leverages key platforms like the U.S.-India Health Dialogue and the Trade Policy Forum. It also leads industry trade missions to India to directly advocate for policy reforms and develop platforms for members to interact with business leaders and government officials. The Life Sciences Executive Committee influences and advances policy and regulatory regimes by promoting best practices and market-based solutions to positively impact life sciences companies in both India and the United States. It formulates an annual work plan and leverages key platforms like the U.S.-India Health Dialogue, the U.S.-India Commercial Dialogue, the Trade Policy Forum, and the U.S.-India IP Dialogue. It also leads industry trade missions to India and USA (a) to directly advocate for policy reforms and develop platforms for members to interact with business leaders and government officials (b) showcase to Central and State Health Ministers/Secretaries to U.S. innovative technologies and discuss policy level issues with the stakeholders.

Pharmaceuticals, Medical Devices, and Health care Providers

 

Intellectual Property (IP)

Pricing and Reimbursement

 

Healthcare Spending and Infrastructure

Meeting with Deputy CEO Ayushman Bharat, New Delhi

Andhra Pradesh

Led an executive-level delegation of USIBC membership including life science companies to meet with Andhra Pradesh governments to discuss investment opportunities, as well as conducted meetings

Government Relations

Coordinated regular meetings with the Indian Embassy and U.S. Government stakeholders on both company-specific and industry-wide issues to raise awareness and understanding. Continue to engage with USTR and GOI Ministry of Commerce and Department of Pharmaceuticals on issues relating to pricing of medical device.

Sandeep Maini serves as the Head of Life Sciences, Food and Agriculture, and Retail at the U.S.-India Business Council. Previously, Sandeep served as the Senior Commercial Specialist at the U.S. Commercial Service, U.S. Embassy, New Delhi for over 30 years and provided clients with expertise in host country counseling, market entry, strategic communication, and advocacy. In this role, Maini promoted U.S. exports, opened foreign markets to American products, protected U.S. commercial interests in India and promoted investment into the United States.

For more information, please contact Sandeep Maini.

Mayank Rohatgi currently serves as the Director of Life Sciences, Manufacturing, and Logistics & Supply Chain at the U.S.-India Business Council at the U.S. Chamber of Commerce. Mayank’s work experience includes 7 years with the Confederation of Indian Industry (CII) and last 18 months as Deputy Director of Medical Technology Association of India (MTal) where he actively worked with companies to provide input on government policies and regulations for the Medical Technology sector.